Adam Koppel insider trades: Cerevel Therapeutics Holdings (CERE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Adam reports to the SEC
and 9 more companies
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | CERE | ↑ Buy | 5,480,052 | $22.81 | $125.0M | Indirect | Oct 18, 2023 (2d) |
| Aug 10, 2021 | SWTX | ↓ Sell | 1,000,000 | $70.25 | $70.3M | Indirect | Aug 12, 2021 (2d) |
| Jul 19, 2021 | RPID | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Jul 21, 2021 (2d) |
| Mar 9, 2021 | SWTX | ↓ Sell | 1,450,000 | $71.50 | $103.7M | Indirect | Mar 11, 2021 (2d) |
| Dec 10, 2020 | DRNA | ↓ Sell | 1,000,000 | $23.40 | $23.4M | Indirect | Dec 14, 2020 (4d) |
| Nov 9, 2020 | CERE | ↑ Buy | 332,293 | $10.30 | $3.4M | Indirect | Nov 12, 2020 (3d) |
| Oct 27, 2020 | CERE | ↑ Buy | 10,000,000 | $10.00 | $100.0M | Indirect | Oct 29, 2020 (2d) |
| Oct 26, 2020 | APTX | ↑ Buy | 3,333,333 | $3.00 | $10.0M | Indirect | Oct 27, 2020 (1d) |
| Jul 28, 2020 | ANNX | ↑ Buy | 400,000 | $17.00 | $6.8M | Indirect | Jul 28, 2020 (0d) |
| Feb 4, 2020 | ARQT | ↑ Buy | 294,117 | $17.00 | $5.0M | Indirect | Feb 6, 2020 (2d) |
| Jan 14, 2020 | APTX | ↑ Buy | 3,333,333 | $3.00 | $10.0M | Indirect | Jan 16, 2020 (2d) |
| Dec 4, 2019 | DRNA | ↓ Sell | 1,500,000 | $24.68 | $37.0M | Indirect | Dec 6, 2019 (2d) |
| Nov 19, 2019 | DRNA | ↓ Sell | 1,750,000 | $22.03 | $38.6M | Indirect | Nov 21, 2019 (2d) |
| Sep 17, 2019 | SWTX | ↑ Buy | 150,000 | $18.00 | $2.7M | Indirect | Sep 19, 2019 (2d) |
| May 29, 2019 | DRNA | ↓ Sell | 1,600,000 | $12.50 | $20.0M | Indirect | May 31, 2019 (2d) |
| Jul 24, 2018 | REPL | ↑ Buy | 500,000 | $15.00 | $7.5M | Indirect | Jul 26, 2018 (2d) |
| Jun 25, 2018 | APTX | ↑ Buy | 400,000 | $16.00 | $6.4M | Indirect | Jun 26, 2018 (1d) |
| Jan 30, 2018 | SLDB | ↑ Buy | 300,000 | $16.00 | $4.8M | Indirect | Feb 1, 2018 (2d) |
| Dec 19, 2017 | MRNS | ↓ Sell | 1,272,547 | $7.88 | $10.0M | Indirect | Dec 19, 2017 (0d) |
| Dec 18, 2017 | DRNA | ↑ Buy | 285,000 | $7.00 | $2.0M | Indirect | Dec 19, 2017 (1d) |
| Jun 6, 2016 | BIIB | ↓ Sell | 555 | $290.00 | $161K | Direct | Jun 7, 2016 (1d) |
| Apr 6, 2016 | BIIB | ↓ Sell | 102 | $275.00 | $28K | Direct | Apr 7, 2016 (1d) |
| Jun 25, 2013 | PTCT | ↑ Buy | 1,250,000 | $15.00 | $18.8M | Indirect | Jun 28, 2013 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Adam Koppel's insider trades
Adam Koppel is an insider at Cerevel Therapeutics Holdings (CERE). Since Jun 25, 2013, Adam has reported 14 open-market purchases worth $304.4M and 9 sales worth $303.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (50 filings), conversions (7 filings), other transactions (6 filings), option exercises (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CERE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.